Life Science Intelligence Blog

LSI's Medtech Startup Tracker is focused exclusively on covering the privately-held innovators changing the medical device landscape. 

Truvian Sciences raises $105M in oversubscribed Series C financing

Funds from the round will be put towards accelerating FDA submission and commercialization for the company’s compact and fully automated benchtop system. The technology is being developed to provide healthcare providers with lab-quality results from a small sample of blood. In addition, the platform is intended to be an affordable diagnostic solution compared to the alternative - off-site labs. To-date, the company has more than $150M. Some of the leading strategics in the diagnostic testing market include BD, Illumina, and Roche.

Start a Free Trial to Medtech Startup Tracker Today

LSI's Medtech Startup Tracker is focused exclusively on covering the privately-held innovators changing the medical device landscape. 

Hyperfine raises $90M in Series D Financing

Hyperfine is the company behind Swoop, an FDA 510(k)-cleared portable MRI machine. Funds from the round will be utilized to accelerate the company’s plans for commercial launch in multiple countries, as well as to aggressively improve the commercial expansion of their technology in the US. In addition to the support of commercialization efforts, the funds will be used to obtain new regulatory clearances, expand uses cases, and improve their technology’s deep learning and AI capabilities. Key strategics in the MRI market include Canon, GE Healthcare, and Siemens.

Start a Free Trial to Medtech Startup Tracker Today

LSI's Medtech Startup Tracker is focused exclusively on covering the privately-held innovators changing the medical device landscape. 

MIVI Neuroscience – next-generation solutions for neurointervention

MIVI is currently developing the DAISe Clot Retrieval System, a catheter deployed solution intended to facilitate clot retrieval. The device uses unique materials that are vessel conforming and prevent mechanical backstop. In addition to the DAISe system, the company is developing the Q Aspiration System. In January 2021, the company closed a Series B round of $35M. The funds from the round will be used fund clinical trials and subsequent commercialization of the two products. Penumbra, Stryker, and Terumo are leading competitors in the market for neurointerventional devices.

Start a Free Trial to Medtech Startup Tracker Today

LSI's Medtech Startup Tracker is focused exclusively on covering the privately-held innovators changing the medical device landscape.  

Resmonics is developing a digital biomarker service for patients with asthma and COPD

Asthma Guardian is the company’s first product. The smartphone application monitors a patient’s breathing in real-time for signs of future exacerbations. The company recently closed a pre-seed financing round. Funds from the round will be used to accelerate market entry for the company’s digital health application, which is anticipated to reach European markets in Q3/21.

Start a Free Trial to Medtech Startup Tracker Today

LSI's Medtech Startup Tracker is focused exclusively on covering the privately-held innovators changing the medical device landscape.  

Noctrix Health raises $17M from Series B round

Noctrix Health is developing wearable therapeutics for the management of chronic illnesses. The company was founded to develop a non-pharmaceutical treatment for restless leg syndrome (RLS). Using a neuromodulation-based approach to treat the painful sensations associated with RLS. The device has received “Breakthrough Device Designation” from the US FDA. Boston Scientific, Medtronic, and Nevro are some of the key strategics in the neuromodulation devices market.

Start a Free Trial to Medtech Startup Tracker Today

LSI's Medtech Startup Tracker is focused exclusively on covering the privately-held innovators changing the medical device landscape.  

CorWave raises $42.8M in Series C round

The company is developing a left ventricular assist device using proprietary wave membrane technology. The technology mimics the physiological flow of blood produced by the native heart. Funds from the round will be used to finalize product development, initiate the process of building manufacturing infrastructure, and initiate clinical testing for regulatory approval. Abbott, LivaNova, and Medtronic are key strategics in the ventricular assist devices market.

Start a Free Trial to Medtech Startup Tracker Today

LSI's Medtech Startup Tracker is focused exclusively on covering the privately-held innovators changing the medical device landscape.  

IsoPlexis completes Series D round, raising $85M

IsoPlexis develops an end-to-end solution proteomics platform for curative medicine development. The IsoSpark platform is capable of evaluating the safety and efficacy of new therapeutics for chronic diseases and cancers. To-date, the company has raised approximately $154M in funding. Illumina, Qiagen, and Thermo Fisher are some of the key strategics in the molecular diagnostics market.

Start a Free Trial to Medtech Startup Tracker Today

LSI's Medtech Startup Tracker is focused exclusively on covering the privately-held innovators changing the medical device landscape.  

Pear Therapeutics raises $80M in Series D round

Pear Therapeutics develops prescription digital therapeutics for the treatment of opioid use and substance use disorder. The company recently received FDA clearance for a third digital therapeutic for the treatment of chronic insomnia. According to a press release from the company, funds from the round will be invested in the commercialization of these three digital therapeutics, including the acceleration of reimbursement coverage.

Start a Free Trial to Medtech Startup Tracker Today

LSI's Medtech Startup Tracker is focused exclusively on covering the privately-held innovators changing the medical device landscape.  

EverlyWell – delivering lab-quality diagnostic testing directly to patients’ homes

EverlyWell is simplifying the process for receiving diagnostic testing by allowing patients to collect and send-off testing samples from home. Results are digitally delivered to patients within a few days. The company offers diagnostic tests for general wellness, men’s and women’s health, metabolic health, sexual health, and COVID-19. EverlyWell recently closed a Series D round worth $175M, bringing the total funds raised to-date by the company to $250M. Key strategics in the diagnostic testing market include Abbott, Illumina, and Roche.

Start a Free Trial to Medtech Startup Tracker Today

LSI's Medtech Startup Tracker is focused exclusively on covering the privately-held innovators changing the medical device landscape.  

GT Medical Technologies closes Series B funding round

The round, funded by MVM Life Science Partners and two other investors, raised $16M to support the commercialization of the company’s FDA-cleared GammaTile Therapy. GT Medical’s GammaTile therapy is placed directly at the location of a brain tumor’s post-surgical excision to irradiate residual tumor cells and prevent tumor cell replication and recurrence. With the completion of this recent fundraising round, the company has raised approximately $29M. Accuray, Elekta, and Varian are some of the key strategics in the market for targeted radiation therapy.

Start a Free Trial to Medtech Startup Tracker Today